Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot your password?

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login
(Shibboleth or Open Athens)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Published: September 2009

Open Access Gateway

A Case of Ketron-Goodman Disease

Carlesimo M.a · Tammaro A.a · Cox C.b · Mari E.a · Fidanza L.a · Narcisi A.a · Cacchi C.c · Camplone G.a

Author affiliations

aU.O.C. Dermatology, bU.O.C. Hematology, and cUnit of Histopathology, II School of Medicine University of Rome ‘Sapienza’, Rome, Italy

Corresponding Author

Alessandra Narcisi, MD

U.O.C. Dermatology, II School of Medicine University of Rome ‘Sapienza’

Via di Grottarossa, 1039, IT–00189 Rome (Italy)

Tel. +39 06 3377 5822, Fax +39 06 3377 5081, E-Mail 123alexa@virgilio.it

Related Articles for ""

Case Rep Dermatol 2009;1:39–43

Do you have an account?

Login Information

Contact Information

I have read the Karger Terms and Conditions and agree.


Pagetoid reticulosis (PR) is a rare form of cutaneous T-cell lymphoma [Mod Pathol 2000;13:502–510]. Two variants of the disease are described: the localized type Woringer-Kolopp disease (WKD) and the disseminated type Ketron-Goodman disease (KGD). KGD may have disseminated lesions, high rate of recurrence and a guarded prognosis [Mod Pathol 2000;13:502–510]. In patients with KGD, therefore, long-term observation is necessary. Disappearance of cutaneous lesions does not mean resolution of the disease [J Am Acad Dermatol 2002;47:183–186]. Herein we report the case of an 84-year-old man with erythematous patches of the trunk and the upper and lower extremities in whom the diagnosis of KGD was made. We describe this case for the rarity of this pathology and for the good response to therapy (IFN).

© 2009 S. Karger AG, Basel

Article / Publication Details

First-Page Preview
Abstract of Published: September 2009

Published online: September 12, 2009
Issue release date: January – December

Number of Print Pages: 5
Number of Figures: 2
Number of Tables: 0

eISSN: 1662-6567 (Online)

For additional information: http://www.karger.com/CDE

Open Access License / Drug Dosage / Disclaimer

Open Access License: This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial 3.0 Unported license (CC BY-NC) (www.karger.com/OA-license), applicable to the online version of the article only. Distribution permitted for non-commercial purposes only.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.